Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
11/29/2001 | US20010047085 Adding to the protein solution a cyclodextrin in an amount sufficient to form a stable complex with the protein, lyophilizing, recovering lyophilized protein/cyclodextrin complex, heating complex to inactivate viruses |
11/29/2001 | US20010047083 Produced by hybridoma cell line ATCC No. HB12003 and progeny thereof; used in detection or treatment of carcinoembryonic antigen associated tumors |
11/29/2001 | US20010046959 Method of treating cancer with anti-neurotrophin agents |
11/29/2001 | US20010046955 Administering an agent that increases the biological activity of a calcitonin gene related peptide receptor in the lungs, such as a corticosteroid, beta-agonist, leukotriene inhibitor, antihistamine or phosphodiesterase inhibitor |
11/29/2001 | US20010046686 Early detetion, prognosis, monitoring and evaluation of response to cancer and other disease therapies |
11/29/2001 | US20010046512 An antibody capable of specifically inhibiting the fusion of an HIV-1 envelope glycoprotein cell with a CD4+ cell without cross reacting with the HIV-1 envelope glycoprotein or CD4 and inhibits infection by strains of HIV-1 |
11/29/2001 | US20010046496 Administering to the human having a disease associated with leukocyte infiltration of mucosal tissues a humanized immunoglobulin or antigen-binding fragment having binidng specificity for alpha 4 beta 7 integrain |
11/29/2001 | US20010046490 Cell surface molecule-induced macrophage activation |
11/29/2001 | US20010045384 Simulated activity of protein a displayed by ligands attached to a cellulose bead surface |
11/29/2001 | DE10032040A1 Antikörper gegen spezielle Formen des proPSA und deren Verwendung in Immunoassays Antibodies against specific forms of proPSA and their use in immunoassays |
11/29/2001 | CA2808215A1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
11/29/2001 | CA2704596A1 Method for examining wt1-related disease |
11/29/2001 | CA2429199A1 Drug metabolizing enzymes |
11/29/2001 | CA2412306A1 Human sodium channel scn12a and scn8a |
11/29/2001 | CA2410520A1 Mutated eukariotic translation initiation factor 2 alpha kinase 3, eif2ak3, in patients with neonatal insulin-dependent diabetes and multiple epiphyseal dysplasia (wolcott-rallison syndrome) |
11/29/2001 | CA2410101A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof |
11/29/2001 | CA2410096A1 Card domain containing polypeptides, encoding nucleic acids, and methods of use |
11/29/2001 | CA2410083A1 Mammalian receptor proteins; related reagents and methods |
11/29/2001 | CA2410082A1 Dnax toll-like receptor 7 (dtlr7) protein, related reagents and methods |
11/29/2001 | CA2410081A1 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
11/29/2001 | CA2409991A1 Bispecific immunoglobulin-like antigen binding proteins and method of production |
11/29/2001 | CA2409299A1 Compositions and methods for the therapy and diagnosis of breast cancer |
11/29/2001 | CA2409298A1 Methods for reducing tumor growth and metastasis by inhibiting mcp-1 activity |
11/29/2001 | CA2408925A1 Synthetic immunogenic but non-amyloidogenic peptides homologous to amyloid beta for induction of an immune response to amyloid beta and amyloid deposits |
11/29/2001 | CA2408739A1 Novel proteins and nucleic acids encoding same, diagnostic and therapeutic uses |
11/29/2001 | CA2408315A1 Aminoacyl trna synthetases |
11/29/2001 | CA2408302A1 Long wavelength engineered fluorescent proteins |
11/29/2001 | CA2408141A1 Neurotransmitter transporters |
11/29/2001 | CA2408140A1 G-protein coupled receptors |
11/29/2001 | CA2408022A1 Pt32 sperm protein, sperm c-yes, oocyte cytoplasmic c-yes, and uses thereof |
11/29/2001 | CA2380443A1 Single-domain antigen-binding antibody fragments derived from llama antibodies |
11/28/2001 | EP1158050A1 Human cysteinyl leukotriene receptor (CysLT2) |
11/28/2001 | EP1158046A1 Superoxide Dismutase-4 |
11/28/2001 | EP1158004A2 Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof |
11/28/2001 | EP1158003A1 Antibodies capable to selectively detect prion PrP Sc isoforms |
11/28/2001 | EP1158002A1 Human G-protein coupled receptor |
11/28/2001 | EP1157276A1 Method for evaluating the intensity of muscular proteolysis |
11/28/2001 | EP1157274A1 Methods of determining altered ndpk functions |
11/28/2001 | EP1157109A2 14273 receptor, a g-protein coupled receptor |
11/28/2001 | EP1157104A2 Pyk2 binding proteins |
11/28/2001 | EP1157043A1 Anti-gpr-9-6 and anti-teck antibodies and methods of identifying modulators of gpr-9-6 and teck functions |
11/28/2001 | EP1157042A1 Production of tetravalent antibodies |
11/28/2001 | EP1157041A2 Antibodies for cancer therapy and diagnosis |
11/28/2001 | EP1157033A1 Synthetic peptides containing protective epitopes for the treatment and prevention of periodontitis associated with porphyromonas gingivalis |
11/28/2001 | EP1156826A1 Product and method for treatment of conditions associated with receptor-desensitization |
11/28/2001 | EP1156825A2 Immunogens comprising a peptide and a carrier derived from h.influenzae protein d |
11/28/2001 | EP1156823A1 Methods for treatment of tumors and metastases using a combination of anti-angiogenic and immuno therapies |
11/28/2001 | EP1156820A1 Vascular endothelial growth factor-2 |
11/28/2001 | EP1156819A1 Methods and compositions for modulating fertility |
11/28/2001 | EP0835326A4 Nucleic acid encoding a signal mediator protein that induces cellular morphological alterations |
11/28/2001 | EP0783520B1 Broadly reactive opsonic antibodies reactive with common staphylococcal antigens |
11/28/2001 | EP0460190B2 Method for detecting malignant diseases |
11/28/2001 | CN1324408A Nucleic acid molecules from rice and their use for the prodn. of modified starch |
11/28/2001 | CN1324405A Novel G protein-coupled receptor proteins, DNAS thereof and ligands to the same |
11/28/2001 | CN1324403A PRV-1 gene and the use thereof |
11/28/2001 | CN1324258A Aglyco products and method of use |
11/28/2001 | CN1324247A Process and materials for the repid detection of i(streptococcus pneumoniae) employing purified antigen-specific antibodies |
11/28/2001 | CN1324242A Novel NEUROPILIN/growth factor binding and use thereof |
11/28/2001 | CN1323901A New polypeptide-DNA topoisomerase I-12 and polynucleotides for coding same |
11/28/2001 | CN1323897A New polypeptide-human ubiquitin C terminal hydrolase 9 and polynucleotides for coding same |
11/28/2001 | CN1323896A New polypeptide-human RNA uncoiling enzyme 12 and polynucleotides for coding same |
11/28/2001 | CN1323838A New polypeptide-human zinc finger protein 16 and polynucleotides for coding same |
11/28/2001 | CN1323830A New polypeptide-human natriuretic peptide acceptor 10 and polynucleotides for coding same |
11/28/2001 | CN1323829A New polypeptide-human ribosomal protein S5-13 and polynucleotides for coding same |
11/28/2001 | CN1323815A New polypeptide-human zinc finger protein 9 and polynucleotides for coding same |
11/28/2001 | CN1323810A New polypeptide-human mitochon dria carrier protein 13 and polynucleotide for coding same |
11/28/2001 | CN1323808A New polypeptide-human sec 13-related protein 10 and polynucleotides for coding same |
11/28/2001 | CN1323803A New human protein with the function of inhibiting cancer cell growth and its coding sequence |
11/28/2001 | CN1323802A New human protein with the function of inhibiting cancer cell growth and its coding sequence |
11/27/2001 | US6323336 PhoH homolog |
11/27/2001 | US6323334 Nucleic acid molecules encoding a 103 gene product and uses therefor |
11/27/2001 | US6323325 Monoclonal antibody for preferential binding to enzymatic polypeptide; for use as a diagnostic tool in drug screening |
11/27/2001 | US6323324 Test kits for detecting the presence of C-terminal hGPIIb fragments |
11/27/2001 | US6323323 Ligand-binding, dimerized polypeptide fusions |
11/27/2001 | US6323322 Single-chain antigen-binding proteins capable of glycosylation, production and uses thereof |
11/27/2001 | US6323321 Monoclonal antibody which binds to an antigen on the megakaryocytic cell for use as diagnostic tool |
11/27/2001 | US6323314 Method of assaying collagen fragments in body fluids, a test KT and means for carrying out the same |
11/27/2001 | US6323175 Composition comprising physiologically compatible liposome, hemoglobin encapsulated in liposome, and nitroxide encapsulated in liposome |
11/27/2001 | US6323030 Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
11/27/2001 | US6323027 Common gamma chain monoclonal antibody blocking agents |
11/27/2001 | US6323026 Mutations in the KCNE1 gene encoding human mink which cause arrhythmia susceptibility thereby establishing KCNE1 as an LQT gene |
11/27/2001 | US6323024 Plasmids for the expression of heterologus genes; for use in treatment and prevention of viral diseases |
11/27/2001 | US6323020 Neutralization-sensitive epitopes of Cryptosporidium parvum |
11/27/2001 | US6323017 Enzymatic polypeptide for prevention and treatment of asthma, exudative tympanitis, hemorrhagic colitis and adult respiratory distress syndrome |
11/27/2001 | US6323004 Modulation of polypeptide display on modified filamentous phage |
11/27/2001 | US6322999 Cloned genes coding for human receptors, and cell lines expressing genes, in order to generate a proper screen for human therapeutic compounds |
11/27/2001 | US6322997 Protein recovery |
11/27/2001 | US6322986 Method for colorectal cancer prognosis and treatment selection |
11/27/2001 | US6322972 Detecting suppressors of ligand binding; transform cells, propagate cells, expose to modulator, compare expression of reporter genes in presence and absence of compound, decrease in expression indicates modulators |
11/27/2001 | US6322794 Seroreactive epitopes on proteins of human papillomavirus (HPV) 18 |
11/27/2001 | US6322788 Anti-bacterial antibodies and methods of use |
11/27/2001 | US6322787 Induction of an anti-tumor immunity by redirecting tumor cells against antigen-presenting cells |
11/27/2001 | CA2145866C Human calcitonin receptor |
11/27/2001 | CA2021912C Erythropoietin (epo) peptides and antibodies directed against these |
11/27/2001 | CA1341322C Interleukin-1 inhibitors |
11/26/2001 | CA2346163A1 Complex for transferring an anionic substance of interest into a cell |
11/26/2001 | CA2308260A1 Blocking cell-division as a therapeutic treatment of pathogenic bacteria |
11/22/2001 | WO2001088538A2 Compositions and methods for epitope mapping |
11/22/2001 | WO2001088203A1 Cloning of rhadinovirus genome and methods for its use |
11/22/2001 | WO2001088162A2 Methods and vectors for generating antibodies in avian species and uses therefor |